Brief: Adial Announces Cary J. Claiborne Has Joined Company As Chief Operating Officer
Dec 8 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL ANNOUNCES CARY J. CLAIBORNE, A RENOWNED
PHARMACEUTICAL
EXECUTIVE AND CURRENT BOARD MEMBER, HAS JOINED THE COMPANY AS
CHIEF OPERATING OFFICER
Source text for Eikon: ID:nGNX4TQ92Q
Further company coverage: ADIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)